International Stem Cell Corporation
OTC: ISCO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Andrey Semechkin
- Employees
- 32
- Headquarters
- San Diego, United States
- IPO year
- 2007
- Market cap
- $1.4M
- Website
- https://www.internationalstemcell.com
Loading ISCO…
Loading profile data…Frequently asked questions about ISCO
What does International Stem Cell Corporation (ISCO) do?
International Stem Cell Corporation (ISCO) is a clinical-stage biotechnology firm dedicated to creating therapeutic and biomedical solutions for a global market, spanning North America, Asia, Europe, and beyond. Central to its offerings are products derived from its proprietary human parthenogenetic stem cells, a unique form of pluripotent stem...
Where does ISCO trade?
International Stem Cell Corporation (ISCO) trades on the Other OTC.
What sector is ISCO in?
International Stem Cell Corporation (ISCO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of International Stem Cell Corporation?
Andrey Semechkin is the chief executive officer of International Stem Cell Corporation (ISCO).
Where is International Stem Cell Corporation headquartered?
International Stem Cell Corporation is headquartered in United States.
Does ISCO pay a dividend?
International Stem Cell Corporation (ISCO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ISCO go public?
International Stem Cell Corporation (ISCO) completed its initial public offering in 2007.